[1] Yue Tong, Sai Xu, Lili Huang*, Chen Chen*. Obesity and insulin resistance: Pathophysiology and treatment. Drug Discovery Today. 2022,27(3): 822-830.
[2] Lei Hu, Zhenzhen Shan, Feng Wang, Xiangdong Gao*, Yue Tong*. Vascular endothelial growth factor B exerts lipid-lowering effect by activating AMPK via VEGFR1. Life Sciences. 2021,276:119401.
[3] Yue Tong, Yu Zhang, Zhenzhen Shan, Yueming Xu, Xiangdong Gao*, Wenbing Yao*. Improving High-fat Diet-induced Obesity and Fatty Liver by Adipose Tissue Targeted Delivery of Vascular Endothelial Growth Factor-B. Life Sciences. 2020,253:117677.
[4] Yue Tong, Shengwei Zhong, Zhenzhen Shan, Wenbing Yao*, Hong Tian*. A novel human anti-BAFF neutralizing monoclonal antibody derived from in vitro immunization. Biomed Pharmacother. 2019,119:109430.
[5] Yue Tong, Xu Fang, Hong Tian, Shengwei Zhong, Liang Jin, Xiangdong Gao*, Wenbing Yao*. De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanine. mAbs, 2019,11(2): 401-410
[6] 《生物技术制药实验指导》2016，参编
[7] 《生物制药工艺学》（第五版）2019，参编
[8] 《生物制药工艺学实验与指导》（第二版）2019，参编
[9] 《新药研究方法与技术》2023，参编
| 生物药物成药性研究/蛋白质多肽类药物的质量研究 |
1. 新型抗胰岛素抵抗药物tPep-VEGF-B的制备及作用机制研究（江苏省自然科学基金）
2. 靶向性血管生成剂tPep-VEGF-B的分子构建及其在胰岛素抵抗中的作用研究（国家自然科学基金青年项目）
3. 基于单B细胞抗体技术的人源抗体开发平台的建立及其应用（国家863项目“青年科学家”专题）
4. 乳糖蛋白残留检测方法的建立及方法学验证（横向）
IL-2生物学活性方法的建立及方法学验证（横向）
[1] Yue Tong, Sai Xu, Lili Huang*, Chen Chen*. Obesity and insulin resistance: Pathophysiology and treatment. Drug Discovery Today. 2022,27(3): 822-830.
[2] Lei Hu, Zhenzhen Shan, Feng Wang, Xiangdong Gao*, Yue Tong*. Vascular endothelial growth factor B exerts lipid-lowering effect by activating AMPK via VEGFR1. Life Sciences. 2021,276:119401.
[3] Yue Tong, Yu Zhang, Zhenzhen Shan, Yueming Xu, Xiangdong Gao*, Wenbing Yao*. Improving High-fat Diet-induced Obesity and Fatty Liver by Adipose Tissue Targeted Delivery of Vascular Endothelial Growth Factor-B. Life Sciences. 2020,253:117677.
[4] Yue Tong, Shengwei Zhong, Zhenzhen Shan, Wenbing Yao*, Hong Tian*. A novel human anti-BAFF neutralizing monoclonal antibody derived from in vitro immunization. Biomed Pharmacother. 2019,119:109430.
[5] Yue Tong, Xu Fang, Hong Tian, Shengwei Zhong, Liang Jin, Xiangdong Gao*, Wenbing Yao*. De novo generation of specific human IgGs by in vitro immunization using autologous proteins containing immunogenic p-nitrophenylalanine. mAbs, 2019,11(2): 401-410
[6] 《生物技术制药实验指导》2016，参编
[7] 《生物制药工艺学》（第五版）2019，参编
[8] 《生物制药工艺学实验与指导》（第二版）2019，参编
[9] 《新药研究方法与技术》2023，参编
